Connect your AI

Oklo OKLO Loss Contingency Accrual

Loss Contingency Accrual at other companies

ALN

Alnylam PharmaceuticalsALNY

——

Other financials

Income statement

Operating income-$51.2M-187%

Net income-$33.1M-237%

EPS (diluted)-$0.19-171%

Balance sheet

Cash & equivalents$15.6M+233%

Total debt$2.6M+46.1%

Total equity$2.6B+880%

Total assets$2.7B+795%

Cash flow

Operating cash flow-$17.9M-45.9%

CapEx$32.8M+9,783%

Free cash flow-$50.7M-303%

Valuation

Market cap$10.64B+186%

Enterprise value$10.63B+186%

Returns & leverage

Return on equity-8.9%—

Debt / equity0×0.0×

Current ratio59.9×+23.7×

Where this comes from

Reported directly by Oklo in its filing.

Tagged under the XBRL concept us-gaap:LossContingencyAccrualAtCarryingValue.

The official record: Oklo’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oklo's loss contingency accrual.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Oklo's loss contingency accrual?: Oklo (OKLO) reported loss contingency accrual of $0 in Q1 2026.